v3 Template
R

Reverb Therapeutics

Biotechnology ~380 employees
Founded
--
Employees (Est.)
~380
19 leaders known
Total Funding
$12.0M
Funding Rounds
1
Last Funding
2025-02-19

About Reverb Therapeutics

Reverb Therapeutics is focused on developing bispecific antibodies that harness the therapeutic potential of the natural immune system through their proprietary Amplify.R platform.

Products & Services

Amplify.R:A bispecific antibody platform that amplifies natural cytokine signaling to enhance immune response.

Specialties

Bispecific Antibodies Immunology Cytokine Signaling Protein Engineering Computational Biology

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Seed
T: -
FT: Seed 		A: 12000000
MR: -
FA: USD $12 Million
FAN: 12000000 		D: 2025-02-19
FD: 2025-02-19 		6 investors
Seed Latest
2025-02-19
$12.0M
6 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

D

David De Graaf

Founder and Chief Executive Officer

S

Surjit Dixit

Founder and Chief Scientific Officer

D

Diana Hausman

Chief Medical Officer

J

Jean M. Jen

Chief Financial Officer

J

John M. Burke

Chief Pharmacology Officer

J

Jennifer Kaufman-Shaw

Strategic IP Advisor

View 16 more team members with Pro

Unlock Full Team Directory

Recent News

Reverb Therapeutics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology
Company Size
~380 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro